More importantly, says Greenberg, the BRCC36 - KIAA0157 complex may represent an attractive
drug development target for inflammatory diseases — an
effort that should be aided immeasurably by the detailed structural information this
study provides.
Although the structure of the mutant form of the protein was not investigated, this
study provides an excellent platform to build upon and will boost
drug development efforts.